Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Urovant Sciences Ltd

(NASDAQ: UROV)
Add to Portfolio
-0.08 (-0.85%)
as of Oct 18, 2019

Last 9.38
Change -0.08 (-0.85%)
Open 9.78
Prev. Close 9.46
Today's Range
9.38
9.88
52wk Range
4.05
14.49
Volume 37,500
Avg Volume 42,795
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
UROV -0.85% +22.45% -23.05%
DJIA -0.95% +1.49% +5.48%
S&P 500 -0.39% +1.64% +7.85%

Key Statistics

Annual EPS -4.00
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 287,020
Weighted Alpha -18.70
Standard Deviation -0.30
Profit Margin N/A
Beta N/A

Growth Rates

YTD +42.34%
1-Year -26.03%

Opinion

Sell Hold Buy

Recent Headlines

Urovant Sciences Parent Company, Roivant Sciences, and

BusinessWire via COMTEX - Fri Sep 06, 09:00AM EDT
Urovant Sciences (Nasdaq: UROV) today announced that its parent company, Roivant Sciences, and Sumitomo Dainippon Pharma Co., Ltd. (TSE: 4506), a leading global Japanese pharmaceutical company, have entered into a non-binding memo(full story)
UROV: 9.38 (-0.08)

Urovant Sciences Appoints James Robinson to its Board

BusinessWire via COMTEX - Wed Mar 06, 08:00AM EST
Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, today announced James Robinson, President and(full story)
ALKS: 18.15 (+0.42), UROV: 9.38 (-0.08)